Human Metabolome Technologies, Inc. (6090) Dividends
Market cap
¥3.7B
P/E ratio
17.3x
Provides high-sensitivity analysis of metabolic compounds to pharmaceutical companies, research institutions, and manufacturers to support drug development and product testing.
Latest Dividend per Share Forecast
18.00JPY
If you buy 100 shares of Human Metabolome Technologies, Inc., the expected annual dividend is 1,800 JPY.
- Dividend Yield
- 2.9%
- Payout Ratio
- 39.4%
Dividend Policy
<p>The company implements a year-end dividend as its standard practice, with interim dividends also paid depending on business performance. The company targets a dividend payout ratio of 30% or higher. Regarding retained earnings, the company secures funds for working capital and strategic investments, and allocates any surplus funds to shareholder returns.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/08/08) | 0 | 18 | 18 | 39.4% |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/08/08) | 0 | 15 | 15 | 34.3% |
| Forecast(2024/08/09) | 0 | 15 | 15 | 31.7% | |
| FY2024 | Actual(2024/08/09) | 0 | 15 | 15 | 36.5% |
| Forecast(2023/08/10) | 0 | 15 | 15 | 31.6% | |
| FY2023 | Actual(2023/08/10) | 0 | 10 | 10 | 20.7% |
| Revision(2023/05/12) | 0 | 10 | 10 | - | |
| Forecast(2022/08/10) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2022/08/10) | 0 | 0 | 0 | - |
| Revision(2022/05/13) | 0 | 0 | 0 | - | |
| Revision(2022/02/14) | 0 | 0 | - | - | |
| Forecast(2021/08/13) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2021/08/13) | 0 | 0 | 0 | - |
| Forecast(2020/11/11) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2020/11/11) | 0 | 0 | 0 | - |